Replies to post #70366 on MyDx Inc. (fka MYDX)

[Bed Bath & Beyonce]

Those snippets are designed to show the history of MYDX and product launches, it's the best comparable data out there to this supposed release of the MYDX pen.

Conspiracies? C'mon, Yazbeck said OrganaDX was coming out in March 2015, and then later said in the 10-K on April 27, 2016 it hasn't even been developed yet. That's a conspiracy?

Agree how things can get in the way, but three and a half years and $31.6M in cumulative net loss from September 16, 2013 to December 31, 2017? Where in the world did that money go to?!

[VerifyandTrust]

The combinations of points below are a concern in my book:

1.) At least 7 DY run trusts owning CS stock

2.) Majority of funding comes from YCIG, DY's Investment company, that also only has one employee, CEO and BOD (DY).

3.) Series A Preferred shares that are always equal to 51% of issued shares...meaning, once 4.9 Billion shares are issued, MYDX is really at 10 Billion issued...creates a misrepresentation when SEC documents denote.

4.) Conversions of Series B Preferred stock at to CS at price/ratio that is instantly profitable for DY (cost the company hundreds of thousands, but is worth millions at the current stock price).

5.) About 2 Billion additional shares issued in the last 3.5 months, since April 2018 (majority 1.75 B from the Series B preferred conversion).

6.) Filling of the 14C to authorize a R/S anytime within the next 12 months

7.) The additional Form 4 on 5/16/18 to convert another 25,000 Preferred B to 250,000,000 CS. The Series B Shares were sold from DY to YCIG for $290,000 (paid by YCIG)...the 250,000,000 had an immediate market value of $750,000! DY gets $290,000 in personal income, his investment company has a $290,000 investment expense, and YCIG can immediately recoup that $290,000 expense by selling less than half the investment. Or sell it all for a profit of $460,000, within YCIG. Which is currently taxable at a much lower corporate rate.

I'm ok with 1,2 & 3 together, but when I see how 4,5,6 & 7 add to that picture, it makes me very weary that shares owned by the trusts and YCIG are being sold to convert shares into cash, held in entities solely run/owned by DY, yet shelter DY via corporate structures. It is beautifully litigious, and very dangerous for external public investors.
The 1st note from the 10-Q below is likely to have been one of the 7 trusts that DY runs, which was $588,000 worth CS that day.



A couple of notes from most recent 10-Q
Subsequent to March 31, 2018, an investor converted 14,700 Series B Preferred stock in to 147,000,000 shares of common stock.

Subsequent to March 31, 2018, YCIG, Inc. converted 175,000 Series B Preferred stock in to 1,750,000,000 shares of common stock.